Why the study?
Does entirely anatomical high-power RF re-ablation safely and effectively eliminate ventricular arrhythmias in patients with refractory left ventricular summit arrhythmias?
Population
15 patients undergoing re-ablation for symptomatic, drug-refractory left ventricular summit arrhythmias…
Design
Cohort
Follow-up
14±9 months
Key result
Entirely anatomical high-power radiofrequency re-ablation achieved acute elimination of ventricular arrhythmias in 47% of patients with previously failed ablations, with no complications.
Authors
Loading...
Modest acute success in small Level 5 series warrants caution; leaves open efficacy and durability pending larger studies.
Observational (n=15)
Does entirely anatomical high-power RF re-ablation safely and effectively eliminate ventricular arrhythmias in patients with refractory left ventricular summit arrhythmias?
Anatomical high-power RF re-ablation is safe and acutely effective in nearly half of patients with refractory left ventricular summit arrhythmias, though advanced strategies are often still required for the remainder.
Szkola et al. (2026) conducted an observational in Symptomatic, drug-refractory left ventricular summit (LVS) arrhythmias after previously failed ablations (n=15). Entirely anatomical high-power radiofrequency (RF) re-ablation was evaluated on Acute success (complete VA elimination during ≥15 minutes of observation, including salbutamol provocation). Entirely anatomical high-power radiofrequency re-ablation achieved acute elimination of ventricular arrhythmias in 47% of patients with previously failed ablations, with no complications.